One of the most significant trends in the API industry is the increasing focus on biologics. Biologics are complex molecules derived from living organisms, and they often require specialized manufacturing processes. This shift towards biologics represents both a challenge and an opportunity for API manufacturers.
An Active Pharmaceutical Ingredient (API) is the biologically active component of a drug product. It is the substance or mixture of substances intended to diagnose, cure, mitigate, treat, or prevent diseases in humans or animals. APIs can be derived from various sources, including synthetic compounds, natural extracts, and biotechnology processes. The quality of an API is paramount, as it directly impacts the safety and efficacy of the final drug product.